| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1310/0CJ5-2ABQ-CB00-6MR6 |
| P698 | PubMed publication ID | 12032883 |
| P50 | author | Vicente Soriano | Q55277832 |
| P2093 | author name string | Carmen de Mendoza | |
| P433 | issue | 3 | |
| P304 | page(s) | 237-248 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | HIV Clinical Trials | Q15756361 |
| P1476 | title | Genetic mechanisms of resistance to NRTI and NNRTI. | |
| P478 | volume | 3 |
| Q36018893 | Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor |
| Q39872168 | Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor |
| Q26852626 | Current perspectives on HIV-1 antiretroviral drug resistance |
| Q34289973 | Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors |
| Q24235724 | Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals |
| Q42620819 | Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon. |
| Q37643598 | In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor |
| Q34083261 | Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG |
| Q27663609 | Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1 |
| Q91582901 | Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors |
| Q24802369 | Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1 |
| Q35962627 | Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus-1 (HIV-1) infected pediatric patients: a cross-sectional study |
| Q34624825 | Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island |
Search more.